Proteinase K and the structure of PrPSc: The good, the bad and the ugly

Virus Research

Volumn 207, Issue , 2015, Pages 120-126

  Silva, Christopher J ^a   Vázquez Fernández, Ester ^b   Onisko, Bruce ^c   Requena, Jesús R ^d  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c OniPro   (United States)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Limited proteolysis; Prion; Proteinase K; PrPSc; PrPSc structure; Solenoid

Indexed keywords

ISOPROTEIN; PRION PROTEIN; PROTEINASE K;

AMINO ACID SEQUENCE; ENGYODONTIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; PROTEIN PROCESSING;

SOLENOIDEA;

ANIMALS; ENDOPEPTIDASE K; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, SECONDARY; PRPSC PROTEINS;

EID: 84938750242     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.03.008     Document Type: Review

References (100)

1. Alper T., Haig D.A., Clarke M.C. The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun. 1966, 22(3):278-284.
2. Amenitsch H., Benetti F., Ramos A., Legname G., Requena J.R. SAXS structural study of PrP reveals ~11nm diameter of basic double intertwined fibers. Prion 2013, 7(6):496-500.
3. Anonymous Commission Regulation (EU) No 1148/2014 of 28 October 2014 amending Annexes II, VII, VIII, IX and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies. Off. J. Eur. Union 2014, L308:66-79.
4. Baldwin M.A. Mass spectrometric analysis of prion proteins. Adv. Protein Chem. 2001, 57:29-54.
5. Baron G.S., Hughson A.G., Raymond G.J., Offerdahl D.K., Barton K.A., Raymond L.D., Dorward D.W., Caughey B. Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra. Biochemistry 2011, 50(21):4479-4490.
6. Barron R.M., Campbell S.L., King D., Bellon A., Chapman K.E., Williamson R.A., Manson J.C. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J. Biol. Chem. 2007, 282(49):35878-35886.
7. Basler K., Oesch B., Scott M., Westaway D., Walchli M., Groth D.F., McKinley M.P., Prusiner S.B., Weissmann C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986, 46(3):417-428.
8. Bellinger-Kawahara C.G., Kempner E., Groth D., Gabizon R., Prusiner S.B. Scrapie prion liposomes and rods exhibit target sizes of 55,000Da. Virology 1988, 164(2):537-541.
9. Bendheim P.E., Bolton D.C. A 54-kDa normal cellular protein may be the precursor of the scrapie agent protease-resistant protein. Proc. Natl. Acad. Sci. U. S. A. 1986, 83(7):2214-2218.
10. Bessen R.A., Marsh R.F. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 1992, 66(4):2096-2101.
11. Bessen R.A., Marsh R.F. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J. Gen. Virol. 1992, 73(2):329-334.
12. Blasche T., Schenck E.V., Balachandran A., Miller M.W., Langenberg J., Frolich K., Steinbach F. Rapid detection of CWD PrP: comparison of tests designed for the detection of BSE or scrapie. Transbound. Emerg. Dis. 2012, 59(5):405-415.
13. Bocharova O.V., Breydo L., Salnikov V.V., Gill A.C., Baskakov I.V. Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob disease. Protein Sci. 2005, 14(5):1222-1232.
14. Bolton D.C., Meyer R.K., Prusiner S.B. Scrapie PrP 27-30 is a sialoglycoprotein. J. Virol. 1985, 53(2):596-606.
15. Browning S., Baker C.A., Smith E., Mahal S.P., Herva M.E., Demczyk C.A., Li J., Weissmann C. Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication. J. Biol. Chem. 2011, 286(47):40962-40973.
16. Castilla J., Saa P., Hetz C., Soto C. In vitro generation of infectious scrapie prions. Cell 2005, 121(2):195-206.
17. Caughey B.W., Dong A., Bhat K.S., Ernst D., Hayes S.F., Caughey W.S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991, 30(31):7672-7680.
18. Chandler R.L. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1961, 1(7191):1378-1379.
19. Chesebro B., Trifilo M., Race R., Meade-White K., Teng C., LaCasse R., Raymond L., Favara C., Baron G., Priola S., Caughey B., Masliah E., Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005, 308(5727):1435-1439.
20. Cobb N.J., Sonnichsen F.D., McHaourab H., Surewicz W.K. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(48):18946-18951.
21. Cooley W.A., Clark J.K., Ryder S.J., Davis L.A., Farrelly S.S., Stack M.J. Evaluation of a rapid western immunoblotting procedure for the diagnosis of bovine spongiform encephalopathy (BSE) in the UK. J. Comp. Pathol. 2001, 125(1):64-70.
22. Cronier S., Gros N., Tattum M.H., Jackson G.S., Clarke A.R., Collinge J., Wadsworth J.D. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem. J. 2008, 416(2):297-305.
23. Deleault N.R., Piro J.R., Walsh D.J., Wang F., Ma J., Geoghegan J.C., Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(22):8546-8551.
24. Detwiler L.A., Baylis M. The epidemiology of scrapie. Rev. Sci. Tech. 2003, 22(1):121-143.
25. Ebeling W., Hennrich N., Klockow M., Metz H., Orth H.D., Lang H. Proteinase K from Tritirachium album Limber. Eur. J. Biochem. 1974, 47(1):91-97.
26. Endo T., Groth D., Prusiner S.B., Kobata A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 1989, 28(21):8380-8388.
27. Gambetti P., Dong Z., Yuan J., Xiao X., Zheng M., Alshekhlee A., Castellani R., Cohen M., Barria M.A., Gonzalez-Romero D., Belay E.D., Schonberger L.B., Marder K., Harris C., Burke J.R., Montine T., Wisniewski T., Dickson D.W., Soto C., Hulette C.M., Mastrianni J.A., Kong Q., Zou W.Q. A novel human disease with abnormal prion protein sensitive to protease. Ann. Neurol. 2008, 63(6):697-708.
28. Gong B., Ramos A., Vazquez-Fernandez E., Silva C.J., Alonso J., Liu Z., Requena J.R. Probing structural differences between PrP(C) and PrP(Sc) by surface nitration and acetylation: evidence of conformational change in the C-terminus. Biochemistry 2011, 50(22):4963-4972.
29. Grassi J., Maillet S., Simon S., Morel N. Progress and limits of TSE diagnostic tools. Vet. Res. 2008, 39(4):33.
30. Gray J.G., Dudas S., Czub S. A study on the analytical sensitivity of 6 BSE tests used by the Canadian BSE reference laboratory. PLoS ONE 2011, 6(3):e17633.
31. Harman J.L., Silva C.J. Bovine spongiform encephalopathy. J. Am. Vet. Med. Assoc. 2009, 234(1):59-72.
32. Hilz H., Wiegers U., Adamietz P. Stimulation of proteinase K action by denaturing agents: application to the isolation of nucleic acids and the degradation of 'masked' proteins. Eur. J. Biochem. 1975, 56(1):103-108.
33. Hope J., Morton L.J., Farquhar C.F., Multhaup G., Beyreuther K., Kimberlin R.H. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J. 1986, 5(10):2591-2597.
34. Hubbard S.J. The structural aspects of limited proteolysis of native proteins. Biochim. Biophys. Acta 1998, 1382(2):191-206.
35. Kascsak R. Reiterating the epitope specificity of prion-specific mAb 3F4. J. Biol. Chem. 2010, 285(20):le5. author reply le6.
36. Keil B. Specificity of Proteolysis 1992, 336. Springer-Verlag, Berlin Heidelberg.
37. Khalili-Shirazi A., Summers L., Linehan J., Mallinson G., Anstee D., Hawke S., Jackson G.S., Collinge J. PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J. Gen. Virol. 2005, 86(Pt 9):2635-2644.
38. Kim C., Haldiman T., Surewicz K., Cohen Y., Chen W., Blevins J., Sy M.S., Cohen M., Kong Q., Telling G.C., Surewicz W.K., Safar J.G. Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C). PLoS Pathog. 2012, 8(8):e1002835.
39. Kirkwood J.K., Cunningham A.A. Epidemiological observations on spongiform encephalopathies in captive wild animals in the British Isles. Vet. Rec. 1994, 135(13):296-303.
40. Klimova N., Makarava N., Baskakov I.V. The diversity and relationship of prion protein self-replicating states. Virus Res. 2015, in this issue.
41. Kocisko D.A., Lansbury P.T., JrCaughey B. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry 1996, 35(41):13434-13442.
42. Lasmezas C.I., Deslys J.P., Robain O., Jaegly A., Beringue V., Peyrin J.M., Fournier J.G., Hauw J.J., Rossier J., Dormont D. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997, 275(5298):402-405.
43. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., Prusiner S.B. Synthetic mammalian prions. Science 2004, 305(5684):673-676.
44. Lizardi P.M., Engelberg A. Rapid isolation of RNA using proteinase K and sodium perchlorate. Anal. Biochem. 1979, 98(1):116-122.
45. Lund C., Olsen C.M., Tveit H., Tranulis M.A. Characterization of the prion protein 3F4 epitope and its use as a molecular tag. J. Neurosci. Methods 2007, 165(2):183-190.
46. Mahal S.P., Jablonski J., Suponitsky-Kroyter I., Oelschlegel A.M., Herva M.E., Oldstone M., Weissmann C. Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain. PLoS Pathog. 2012, 8(6):e1002746.
47. Makarava N., Kovacs G.G., Savtchenko R., Alexeeva I., Budka H., Rohwer R.G., Baskakov I.V. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog. 2011, 7(12):e1002419.
48. Makarava N., Kovacs G.G., Savtchenko R., Alexeeva I., Ostapchenko V.G., Budka H., Rohwer R.G., Baskakov I.V. A new mechanism for transmissible prion diseases. J. Neurosci. 2012, 32(21):7345-7355.
49. Manson J.C., Jamieson E., Baybutt H., Tuzi N.L., Barron R., McConnell I., Somerville R., Ironside J., Will R., Sy M.S., Melton D.W., Hope J., Bostock C. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J. 1999, 18(23):6855-6864.
50. Marsh R.F., Hadlow W.J. Transmissible mink encephalopathy. Rev. Sci. Tech. 1992, 11(2):539-550.
51. McKinley M.P., Bolton D.C., Prusiner S.B. A protease-resistant protein is a structural component of the scrapie prion. Cell 1983, 35(1):57-62.
52. Meloni D., Davidse A., Langeveld J.P., Varello K., Casalone C., Corona C., Balkema-Buschmann A., Groschup M.H., Ingravalle F., Bozzetta E. EU-approved rapid tests for bovine spongiform encephalopathy detect atypical forms: a study for their sensitivities. PLoS One 2012, 7(9):e43133.
53. Merz P.A., Somerville R.A., Wisniewski H.M., Iqbal K. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol. 1981, 54(1):63-74.
54. Morihara K., Tsuzuki H. Specificity of proteinase K from Tritirachiumn album limber for synthetic peptides. Agr. Biol. Chem. 1975, 39(7):1489-1492.
55. Nguyen J.T., Inouye H., Baldwin M.A., Fletterick R.J., Cohen F.E., Prusiner S.B., Kirschner D.A. X-ray diffraction of scrapie prion rods and PrP peptides. J. Mol. Biol. 1995, 252(4):412-422.
56. Onisko B., Fernandez E.G., Freire M.L., Schwarz A., Baier M., Camina F., Garcia J.R., Rodriguez-Segade Villamarin S., Requena J.R. Probing PrPSc structure using chemical cross-linking and mass spectrometry: evidence of the proximity of Gly90 amino termini in the PrP 27-30 aggregate. Biochemistry 2005, 44(30):10100-10109.
57. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(23):10962-10966.
58. Paramithiotis E., Pinard M., Lawton T., LaBoissiere S., Leathers V.L., Zou W.Q., Estey L.A., Lamontagne J., Lehto M.T., Kondejewski L.H., Francoeur G.P., Papadopoulos M., Haghighat A., Spatz S.J., Head M., Will R., Ironside J., O'Rourke K., Tonelli Q., Ledebur H.C., Chakrabartty A., Cashman N.R. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 2003, 9(7):893-899.
59. Pastrana M.A., Sajnani G., Onisko B., Castilla J., Morales R., Soto C., Requena J.R. Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 2006, 45(51):15710-15717.
60. Peretz D., Williamson R.A., Matsunaga Y., Serban H., Pinilla C., Bastidas R.B., Rozenshteyn R., James T.L., Houghten R.A., Cohen F.E., Prusiner S.B., Burton D.R. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 1997, 273(3):614-622.
61. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216(4542):136-144.
62. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(23):13363-13383.
63. Prusiner S.B., Groth D., Serban A., Stahl N., Gabizon R. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(7):2793-2797.
64. Prusiner S.B., Groth D.F., Bildstein C., Masiarz F.R., McKinley M.P., Cochran S.P. Electrophoretic properties of the scrapie agent in agarose gels. Proc. Natl. Acad. Sci. U. S. A. 1980, 77(5):2984-2988.
65. Prusiner S.B., Groth D.F., Bolton D.C., Kent S.B., Hood L.E. Purification and structural studies of a major scrapie prion protein. Cell 1984, 38(1):127-134.
66. Requena J.R., Wille H. The structure of the infectious prion protein: experimental data and molecular models. Prion 2014, 8(1):60-66.
67. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., Wuthrich K. NMR structure of the mouse prion protein domain PrP(121-321). Nature 1996, 382(6587):180-182.
68. Rudd P.M., Endo T., Colominas C., Groth D., Wheeler S.F., Harvey D.J., Wormald M.R., Serban H., Prusiner S.B., Kobata A., Dwek R.A. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(23):13044-13049.
69. Saenger W. Chapter 714 - proteinase K. Handbook of Proteolytic Enzymes, 2013, 3:3240-3242. Academic Press, San Diego. 3rd ed.
70. Safar J., Roller P.P., Gajdusek D.C., Gibbs C.J. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 1993, 268(27):20276-20284.
71. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F.E., Prusiner S.B. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 1998, 4(10):1157-1165.
72. Sajnani G., Pastrana M.A., Dynin I., Onisko B., Requena J.R. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry. J. Mol. Biol. 2008, 382(1):88-98.
73. Sajnani G., Silva C.J., Ramos A., Pastrana M.A., Onisko B.C., Erickson M.L., Antaki E.M., Dynin I., Vazquez-Fernandez E., Sigurdson C.J., Carter J.M., Requena J.R. PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP. PLoS Pathog. 2012, 8(3):e1002547.
74. Schaller O., Fatzer R., Stack M., Clark J., Cooley W., Biffiger K., Egli S., Doherr M., Vandevelde M., Heim D., Oesch B., Moser M. Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol. 1999, 98(5):437-443.
75. Sikorska B., Knight R., Ironside J.W., Liberski P.P. Creutzfeldt-Jakob disease. Adv. Exp. Med. Biol. 2012, 724:76-90.
76. Silva C.J. Using small molecule reagents to selectively modify epitopes based on their conformation. Prion 2012, 6(2):163-173.
77. Silva C.J. Applying the tools of chemistry (mass spectrometry and covalent modification by small molecule reagents) to the detection of prions and the study of their structure. Prion 2014, 8(1):42-50.
78. Silva C.J., Dynin I., Erickson M.L., Requena J.R., Balachandran A., Hui C., Onisko B.C., Carter J.M. Oxidation of methionine 216 in sheep and elk prion protein is highly dependent upon the amino acid at position 218 but is not important for prion propagation. Biochemistry 2013, 52(12):2139-2147.
79. Silva C.J., Onisko B.C., Dynin I., Erickson M.L., Vensel W.H., Requena J.R., Antaki E.M., Carter J.M. Assessing the role of oxidized methionine at position 213 in the formation of prions in hamsters. Biochemistry 2010, 49(9):1854-1861.
80. Silveira J.R., Raymond G.J., Hughson A.G., Race R.E., Sim V.L., Hayes S.F., Caughey B. The most infectious prion protein particles. Nature 2005, 437(7056):257-261.
81. Sim V.L., Caughey B. Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol. Aging 2009, 30(12):2031-2042.
82. Smirnovas V., Baron G.S., Offerdahl D.K., Raymond G.J., Caughey B., Surewicz W.K. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 2011, 18(4):504-506.
83. Stahl N., Baldwin M., Teplow D.B., Hood L.E., Beavis R., Chait B., Gibson B.W., Burlingame A.L., Prusiner S.B. Cataloging post-translational modifications of the scrapie prion protein by mass spectrometry. Prion Diseases of Humans and Animals 1992, 361-379. Ellis Horwood, New York. S.B. Prusiner, J. Collinge, J. Powell, B. Anderton (Eds.).
84. Stahl N., Baldwin M.A., Teplow D.B., Hood L., Gibson B.W., Burlingame A.L., Prusiner S.B. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 1993, 32(8):1991-2002.
85. Stahl N., Borchelt D.R., Hsiao K., Prusiner S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987, 51(2):229-240.
86. Stimson E., Hope J., Chong A., Burlingame A.L. Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 1999, 38(15):4885-4895.
87. Surewicz W.K., Apostol M.I. Prion protein and its conformational conversion: a structural perspective. Top. Curr. Chem 2011, 305:135-167.
88. Turk E., Teplow D.B., Hood L.E., Prusiner S.B. Purification and properties of the cellular and scrapie hamster prion proteins. Eur. J. Biochem. 1988, 176(1):21-30.
89. Tzaban S., Friedlander G., Schonberger O., Horonchik L., Yedidia Y., Shaked G., Gabizon R., Taraboulos A. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002, 41(42):12868-12875.
90. Van Melckebeke H., Wasmer C., Lange A., Ab E., Loquet A., Bockmann A., Meier B.H. Atomic-resolution three-dimensional structure of HET-s(218-289) amyloid fibrils by solid-state NMR spectroscopy. J. Am. Chem. Soc. 2010, 132(39):13765-13775.
91. Vazquez-Fernandez E., Alonso J., Pastrana M.A., Ramos A., Stitz L., Vidal E., Dynin I., Petsch B., Silva C.J., Requena J.R. Structural organization of mammalian prions as probed by limited proteolysis. PLoS ONE 2012, 7(11):e50111.
92. Wan W., Wille H., Stohr J., Baxa U., Prusiner S.B., Stubbs G. Degradation of fungal prion HET-s(218-289) induces formation of a generic amyloid fold. Biophys. J. 2012, 102(10):2339-2344.
93. Wang F., Wang X., Yuan C.G., Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010, 327(5969):1132-1135.
94. Wasmer C., Lange A., Van Melckebeke H., Siemer A.B., Riek R., Meier B.H. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science 2008, 319(5869):1523-1526.
95. Wille H., Bian W., McDonald M., Kendall A., Colby D.W., Bloch L., Ollesch J., Borovinskiy A.L., Cohen F.E., Prusiner S.B., Stubbs G. Natural and synthetic prion structure from X-ray fiber diffraction. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(40):16990-16995.
96. Williams E.S. Chronic wasting disease. Vet. Pathol. 2005, 42(5):530-549.
97. Xiao X., Cali I., Dong Z., Puoti G., Yuan J., Qing L., Wang H., Kong Q., Gambetti P., Zou W.Q. Protease-sensitive prions with 144-bp insertion mutations. Aging (Albany, NY) 2013, 5(3):155-173.
98. Zanusso G., Farinazzo A., Prelli F., Fiorini M., Gelati M., Ferrari S., Righetti P.G., Rizzuto N., Frangione B., Monaco S. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J. Biol. Chem. 2004, 279(37):38936-38942.
99. Zou W.Q., Capellari S., Parchi P., Sy M.S., Gambetti P., Chen S.G. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J. Biol. Chem. 2003, 278(42):40429-40436.
100. Zou W.Q., Puoti G., Xiao X., Yuan J., Qing L., Cali I., Shimoji M., Langeveld J.P., Castellani R., Notari S., Crain B., Schmidt R.E., Geschwind M., Dearmond S.J., Cairns N.J., Dickson D., Honig L., Torres J.M., Mastrianni J., Capellari S., Giaccone G., Belay E.D., Schonberger L.B., Cohen M., Perry G., Kong Q., Parchi P., Tagliavini F., Gambetti P. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann. Neurol. 2010, 68(2):162-172.